Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG-perfusion for Kidney and Liver Transplants
NCT03377283Phase 4Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Aug 2012
- Primary completion
- Mar 2015
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
01
Overview
Phase 4, randomised trial of antithymocyte globulin rabbit in ischemia-reperfusion injury (IRI) (2 arms), sponsored by Medical University of Innsbruck. Primary endpoint: Graft function at Day 7. Started Aug 2012; status: completed.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT03377283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03377283.